Published in PLoS One on January 22, 2010
Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc Res (2011) 1.85
Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res (2011) 1.84
miR-212/132 expression and functions: within and beyond the neuronal compartment. Nucleic Acids Res (2012) 1.76
Involvement of argonaute proteins in gene silencing and activation by RNAs complementary to a non-coding transcript at the progesterone receptor promoter. Nucleic Acids Res (2010) 1.74
Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. Cancer Res (2010) 1.54
Small RNA and transcriptional upregulation. Wiley Interdiscip Rev RNA (2011) 1.36
MALAT1 promotes colorectal cancer cell proliferation/migration/invasion via PRKA kinase anchor protein 9. Biochim Biophys Acta (2014) 1.30
Transcriptional gene silencing in mammalian cells by miRNA mimics that target gene promoters. Nucleic Acids Res (2011) 1.26
Argonaute and the nuclear RNAs: new pathways for RNA-mediated control of gene expression. Nucleic Acid Ther (2012) 1.10
Defining features and exploring chemical modifications to manipulate RNAa activity. Curr Pharm Biotechnol (2010) 1.09
Analysis of nuclear RNA interference in human cells by subcellular fractionation and Argonaute loading. Nat Protoc (2014) 0.97
Autoregulation of lin-4 microRNA transcription by RNA activation (RNAa) in C. elegans. Cell Cycle (2014) 0.96
What are natural antisense transcripts good for? Biochem Soc Trans (2010) 0.94
Targeted p21WAF1/CIP1 activation by RNAa inhibits hepatocellular carcinoma cells. Nucleic Acid Ther (2012) 0.94
Induction of NANOG expression by targeting promoter sequence with small activating RNA antagonizes retinoic acid-induced differentiation. Biochem J (2012) 0.93
RNA-mediated gene activation. Epigenetics (2013) 0.92
Formulation of Small Activating RNA Into Lipidoid Nanoparticles Inhibits Xenograft Prostate Tumor Growth by Inducing p21 Expression. Mol Ther Nucleic Acids (2012) 0.91
mirCoX: a database of miRNA-mRNA expression correlations derived from RNA-seq meta-analysis. BMC Bioinformatics (2013) 0.90
A non-canonical landscape of the microRNA system. Front Genet (2014) 0.89
miRNA goes nuclear. RNA Biol (2012) 0.87
Anti-cancer effects of p21WAF1/CIP1 transcriptional activation induced by dsRNAs in human hepatocellular carcinoma cell lines. Acta Pharmacol Sin (2011) 0.86
Small RNA and its application in andrology and urology. Transl Androl Urol (2012) 0.84
Regulation of mammalian transcription and splicing by Nuclear RNAi. Nucleic Acids Res (2015) 0.83
Integration analysis of microRNA and mRNA expression profiles in human peripheral blood lymphocytes cultured in modeled microgravity. Biomed Res Int (2014) 0.83
MicroRNA miR-324-3p induces promoter-mediated expression of RelA gene. PLoS One (2013) 0.83
Gene Expression Profile Changes After Short-activating RNA-mediated Induction of Endogenous Pluripotency Factors in Human Mesenchymal Stem Cells. Mol Ther Nucleic Acids (2012) 0.82
RNAa-mediated overexpression of WT1 induces apoptosis in HepG2 cells. World J Surg Oncol (2012) 0.82
The varied roles of nuclear argonaute-small RNA complexes and avenues for therapy. Mol Ther Nucleic Acids (2014) 0.81
Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer. Cell Rep (2016) 0.80
MicroRNA profiling in the mouse hypothalamus reveals oxytocin-regulating microRNA. J Neurochem (2013) 0.80
Identification of small activating RNAs that enhance endogenous OCT4 expression in human mesenchymal stem cells. Stem Cells Dev (2014) 0.80
Targeted p53 activation by saRNA suppresses human bladder cancer cells growth and metastasis. J Exp Clin Cancer Res (2016) 0.79
A Short-activating RNA Oligonucleotide Targeting the Islet β-cell Transcriptional Factor MafA in CD34(+) Cells. Mol Ther Nucleic Acids (2013) 0.79
Stable association of RNAi machinery is conserved between the cytoplasm and nucleus of human cells. RNA (2016) 0.78
Small activating RNA restores the activity of the tumor suppressor HIC-1 on breast cancer. PLoS One (2014) 0.78
Oligonucleotide treatment causes flax β-glucanase up-regulation via changes in gene-body methylation. BMC Plant Biol (2014) 0.78
RNAs specifically affect gene expression in a length, position and sequence dependent manner. Int J Clin Exp Pathol (2014) 0.77
Overexpression of p53 activated by small activating RNA suppresses the growth of human prostate cancer cells. Onco Targets Ther (2016) 0.77
Inducing gene expression by targeting promoter sequences using small activating RNAs. J Biol Methods (2015) 0.77
Human RNAi pathway: crosstalk with organelles and cells. Funct Integr Genomics (2013) 0.77
A Network of Regulations by Small Non-Coding RNAs: The P-TEFb Kinase in Development and Pathology. Front Genet (2011) 0.77
Small double-stranded RNA mediates the anti-cancer effects of p21WAF1/ClP1 transcriptional activation in a human glioma cell line. Yonsei Med J (2014) 0.76
Small activating RNA binds to the genomic target site in a seed-region-dependent manner. Nucleic Acids Res (2016) 0.76
saRNA-guided Ago2 targets the RITA complex to promoters to stimulate transcription. Cell Res (2016) 0.76
A Novel Method for Gene-Specific Enhancement of Protein Translation by Targeting 5'UTRs of Selected Tumor Suppressors. PLoS One (2016) 0.76
A New Gene Therapy Approach for Cardiovascular Disease by Non-coding RNAs Acting in the Nucleus. Mol Ther Nucleic Acids (2014) 0.76
Small activating ribonucleic acid reverses tyrosine kinase inhibitor resistance in epidermal growth factor receptor-mutant lung cancer by increasing the expression of phosphatase and tensin homolog. Thorac Cancer (2016) 0.75
Differential Regulation of Vascular Endothelial Growth Factors by Promoter-targeted shRNAs. Mol Ther Nucleic Acids (2015) 0.75
Enhancing DPYSL3 gene expression via a promoter-targeted small activating RNA approach suppresses cancer cell motility and metastasis. Oncotarget (2016) 0.75
RNA Activation of the Vascular Endothelial Growth Factor Gene (VEGF) Promoter by Double-Stranded RNA and Hypoxia: Role of Noncoding VEGF Promoter Transcripts. Mol Cell Biol (2016) 0.75
Small activating RNA induces myogenic differentiation of rat adipose-derived stem cells by upregulating MyoD. Int Braz J Urol (2015) 0.75
Size unbiased representative enzymatically generated RNAi (SURER) library and application for RNAi therapeutic screens. Nucleic Acid Ther (2014) 0.75
Demystifying the mechanistic and functional aspects of p21 gene activation with double-stranded RNAs in human cancer cells. J Exp Clin Cancer Res (2016) 0.75
Small RNA-directed epigenetic programming of embryonic stem cell cardiac differentiation. Sci Rep (2017) 0.75
Reactivation of HIC-1 gene by saRNA inhibits clonogenicity and invasiveness in breast cancer cells. Oncol Lett (2014) 0.75
Oligodeoxynucleotides Can Transiently Up- and Downregulate CHS Gene Expression in Flax by Changing DNA Methylation in a Sequence-Specific Manner. Front Plant Sci (2017) 0.75
Switching from repression to activation: microRNAs can up-regulate translation. Science (2007) 17.00
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature (2007) 16.95
Restoration of p53 function leads to tumour regression in vivo. Nature (2007) 12.62
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res (1994) 9.00
RNAi-mediated gene silencing in non-human primates. Nature (2006) 7.60
The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature (1998) 7.38
Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature (2008) 7.18
MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A (2008) 6.38
Modeling the therapeutic efficacy of p53 restoration in tumors. Cell (2006) 5.95
Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat Chem Biol (2007) 5.05
Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci U S A (2006) 4.90
Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates. Proc Natl Acad Sci U S A (2008) 4.57
Bidirectional transcription directs both transcriptional gene activation and suppression in human cells. PLoS Genet (2008) 4.45
Roles for Nkx3.1 in prostate development and cancer. Genes Dev (1999) 4.30
Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Cancer Res (1997) 3.67
Antisense transcripts are targets for activating small RNAs. Nat Struct Mol Biol (2008) 3.02
A small modulatory dsRNA specifies the fate of adult neural stem cells. Cell (2004) 2.95
MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia. Proc Natl Acad Sci U S A (2008) 2.25
The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4. Eur J Immunol (1997) 2.14
Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis. Cytometry (1998) 2.11
Efficient regulation of VEGF expression by promoter-targeted lentiviral shRNAs based on epigenetic mechanism: a novel example of epigenetherapy. Circ Res (2009) 1.55
Treatment of type 1 diabetes with adipose tissue-derived stem cells expressing pancreatic duodenal homeobox 1. Stem Cells Dev (2009) 1.12
Direct CNS delivery of siRNA mediates robust silencing in oligodendrocytes. Oligonucleotides (2009) 0.97
CXCR4 enhances engraftment of muscle progenitor cells. Muscle Nerve (2009) 0.92
Animal models for target diseases in gene therapy--using DNA and siRNA delivery strategies. Pharm Res (2008) 0.90
Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev (2003) 17.64
The sequence and de novo assembly of the giant panda genome. Nature (2009) 15.76
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
The Genomes of Oryza sativa: a history of duplications. PLoS Biol (2005) 7.67
A draft sequence for the genome of the domesticated silkworm (Bombyx mori). Science (2004) 6.62
A DNA integrity network in the yeast Saccharomyces cerevisiae. Cell (2006) 6.61
MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A (2008) 6.38
A genetic variation map for chicken with 2.8 million single-nucleotide polymorphisms. Nature (2004) 5.24
Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci U S A (2006) 4.90
A robust toolkit for functional profiling of the yeast genome. Mol Cell (2004) 4.69
Ras and Rap control AMPA receptor trafficking during synaptic plasticity. Cell (2002) 4.50
Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet (2013) 3.87
American Urological Association guideline on the management of priapism. J Urol (2003) 3.77
Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. J Cereb Blood Flow Metab (2009) 2.87
Defining stem and progenitor cells within adipose tissue. Stem Cells Dev (2008) 2.63
EGF-induced ERK activation promotes CK2-mediated disassociation of alpha-Catenin from beta-Catenin and transactivation of beta-Catenin. Mol Cell (2009) 2.50
Retracted Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease. Nat Med (2010) 2.43
Role for Dpy-30 in ES cell-fate specification by regulation of H3K4 methylation within bivalent domains. Cell (2011) 2.30
Overexpression of exportin 5 enhances RNA interference mediated by short hairpin RNAs and microRNAs. RNA (2004) 2.21
Molecular mechanisms related to parturition-induced stress urinary incontinence. Eur Urol (2008) 2.17
miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2. J Cell Biol (2012) 2.15
Treatment of erectile dysfunction in the obese type 2 diabetic ZDF rat with adipose tissue-derived stem cells. J Sex Med (2010) 1.99
Effect of oral ALA supplementation on oxidative stress and insulin sensitivity among overweight/obese adults: a double-blinded, randomized, controlled, cross-over intervention trial. Int J Cardiol (2012) 1.98
Correction of penile curvature using the 16-dot plication technique: a review of 132 patients. J Urol (2002) 1.96
Defining adipose tissue-derived stem cells in tissue and in culture. Histol Histopathol (2010) 1.95
Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action. Neurourol Urodyn (2011) 1.93
Rap2-JNK removes synaptic AMPA receptors during depotentiation. Neuron (2005) 1.90
Injections of adipose tissue-derived stem cells and stem cell lysate improve recovery of erectile function in a rat model of cavernous nerve injury. J Sex Med (2010) 1.87
Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res (2011) 1.84
Physiology of penile erection and pathophysiology of erectile dysfunction. Urol Clin North Am (2005) 1.81
A longitudinal study of blood pressure variability in African-American and European American youth. J Hypertens (2010) 1.76
Neuron-like differentiation of adipose tissue-derived stromal cells and vascular smooth muscle cells. Differentiation (2006) 1.73
Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway. Clin Cancer Res (2006) 1.73
Treatment of stress urinary incontinence with adipose tissue-derived stem cells. Cytotherapy (2010) 1.71
T-shaped shunt and intracavernous tunneling for prolonged ischemic priapism. J Urol (2009) 1.69
MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway. Hepatology (2013) 1.69
Upregulation of penile brain-derived neurotrophic factor (BDNF) and activation of the JAK/STAT signalling pathway in the major pelvic ganglion of the rat after cavernous nerve transection. Eur Urol (2006) 1.67
Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth. Cancer Res (2012) 1.65
Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamics. Genes Dev (2012) 1.64
Brain activation and sexual arousal in healthy, heterosexual males. Brain (2002) 1.62
(E)-N'-[4-(Dimethyl-amino)-benzyl-idene]-2-meth-oxy-benzohydrazide. Acta Crystallogr Sect E Struct Rep Online (2010) 1.60
LncRNAs expression signatures of renal clear cell carcinoma revealed by microarray. PLoS One (2012) 1.59
Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res (2008) 1.58
Complications of porcine small intestine submucosa graft for Peyronie's disease. J Urol (2007) 1.57
Chapter 1: The management of erectile dysfunction: an AUA update. J Urol (2005) 1.55
Penile sonographic and clinical characteristics in men with Peyronie's disease. J Sex Med (2009) 1.55
Psychological impact of erectile dysfunction: validation of a new health related quality of life measure for patients with erectile dysfunction. J Urol (2002) 1.54
Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. Cancer Res (2010) 1.54
Quantitative characterization of intrinsic disorder in polyglutamine: insights from analysis based on polymer theories. Biophys J (2007) 1.53
miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget (2010) 1.53
Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner. Clin Cancer Res (2012) 1.52
A genome-wide methylation study on obesity: differential variability and differential methylation. Epigenetics (2013) 1.51
Leukocyte telomere length in healthy Caucasian and African-American adolescents: relationships with race, sex, adiposity, adipokines, and physical activity. J Pediatr (2010) 1.50
The effect of intracavernous injection of adipose tissue-derived stem cells on hyperlipidemia-associated erectile dysfunction in a rat model. J Sex Med (2010) 1.50
Genetic and environmental determinants of lipid profile in black and white youth: a study of four candidate genes. Ethn Dis (2005) 1.47
Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res (2011) 1.46
Erection of the human penis and its morphological and vascular basis by Guiseppe Conti. J Sex Med (2008) 1.45
Labeling and tracking of mesenchymal stromal cells with EdU. Cytotherapy (2009) 1.45
Stem cell therapy for erectile dysfunction: a critical review. Stem Cells Dev (2011) 1.44
Effects of high glucose on human cavernous endothelial cells. Urology (2012) 1.44
Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants. Stem Cells Dev (2012) 1.44
Improving erectile function by silencing phosphodiesterase-5. J Urol (2005) 1.43
Atomistic simulations of the effects of polyglutamine chain length and solvent quality on conformational equilibria and spontaneous homodimerization. J Mol Biol (2008) 1.43
The E-cadherin -160 C/A polymorphism and prostate cancer risk in white and black American men. J Urol (2006) 1.43
Cavernous nerve repair with allogenic adipose matrix and autologous adipose-derived stem cells. Urology (2011) 1.43
Summary of the recommendations on sexual dysfunctions in men. J Sex Med (2010) 1.42
Ras signaling mechanisms underlying impaired GluR1-dependent plasticity associated with fragile X syndrome. J Neurosci (2008) 1.42
A polymer physics perspective on driving forces and mechanisms for protein aggregation. Arch Biochem Biophys (2007) 1.41
c-Jun downregulation by HDAC3-dependent transcriptional repression promotes osmotic stress-induced cell apoptosis. Mol Cell (2007) 1.40
Antitumor effect of dsRNA-induced p21(WAF1/CIP1) gene activation in human bladder cancer cells. Mol Cancer Ther (2008) 1.39
The effect of neural embryonic stem cell therapy in a rat model of cavernosal nerve injury. BJU Int (2004) 1.37
Small RNA and transcriptional upregulation. Wiley Interdiscip Rev RNA (2011) 1.36
Fibroblast growth factor 2 promotes endothelial differentiation of adipose tissue-derived stem cells. J Sex Med (2008) 1.35
A pathophysiology-based approach to the management of early priapism. Asian J Androl (2012) 1.35
Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med (2010) 1.35
T-shunt with or without tunnelling for prolonged ischaemic priapism. BJU Int (2008) 1.33
Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis. Clin Cancer Res (2010) 1.31
Ethnic differences in resting heart rate variability: a systematic review and meta-analysis. Psychosom Med (2015) 1.31
Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat model. J Sex Med (2012) 1.30
Human hHpr1/p84/Thoc1 regulates transcriptional elongation and physically links RNA polymerase II and RNA processing factors. Mol Cell Biol (2005) 1.30
Multiple conformations of phosphodiesterase-5: implications for enzyme function and drug development. J Biol Chem (2006) 1.29